Market
What will be the impact of RFK Jr.'s investigation on pharma companies by end of 2025?
2
Resolution / Starting Odds
Significant negative impact • 25%
No significant impact • 25%
Positive impact • 25%
Investigation not concluded • 25%
Stock market reports, industry analyses, and official statements
Story
Trump Appoints RFK Jr. to Investigate Vaccines' Link to Autism as HHS Head, Emphasizing Legacy Focus
Dec 8, 2024, 02:47 PM
President Donald Trump announced that Robert F. Kennedy Jr. will lead an investigation as the head of the Department of Health and Human Services (HHS) into childhood vaccines and their potential link to autism, as well as other possible causes. During a press interaction, NBC's Kristen Welker questioned Trump on whether he intends to eliminate childhood vaccinations. Trump responded, stating that he would consider ending vaccinations if they are deemed dangerous for children. This initiative is part of Trump's broader agenda, which he views as a significant aspect of his legacy, positioning himself as a leader against the influence of pharmaceutical companies.
View original story
Similar markets
Other response • 25%
Support the proposal • 25%
Oppose the proposal • 25%
Remain neutral • 25%
Inconclusive • 25%
No link found • 25%
Link found • 25%
Inconclusive results • 25%
No report released • 25%
Investigation not completed • 25%
Vaccines not linked to autism • 25%
Vaccines linked to autism • 25%
Investigation incomplete • 25%
Confirms link • 25%
Appointed and active • 25%
Other outcome • 25%
Appointed but inactive • 25%
Not appointed • 25%
Increased distribution • 25%
Other • 25%
No change • 25%
Decreased distribution • 25%
Increased vaccine skepticism • 25%
Decreased vaccine skepticism • 25%
No significant change • 25%
Insufficient data • 25%
Decrease in trust • 25%
Increase in trust • 25%
No change • 25%
Mixed results • 25%
Supportive • 25%
Mixed reactions • 25%
Neutral • 25%
Critical • 25%
Decrease by more than 5% • 25%
Fluctuate without clear trend • 25%
No significant change • 25%
Increase by more than 5% • 25%
Other outcome • 25%
Fully implemented • 25%
Partially implemented • 25%
Not implemented • 25%
Mixed • 25%
Pro-vaccine • 25%
Anti-vaccine • 25%
Neutral • 25%